Jiya in an amended S-1 said it may issue a maximum of 11.5 million shares, which would generate up to $115 million in the offering. The SPAC is focused on biopharmaceutical companies. Read more.
Related Posts
FirstMark Acquisition II Files for $200M IPO
The new SPAC plans to target businesses in the technology industry.
Tailwind International Acquisition Prices Upsized $300M IPO
Tailwind in its initial S-1 filing has said it will target international consumer internet and other high-growth technology companies in international markets, with a focus on the European market.
ExcelFin Acquisition Wants 6 More Months
The SPAC has a merger agreement with Baird Medical, the largest microwave ablation medical device provider for thyroid nodules and breast lump treatment in China.
Levere Holdings Prices $250M IPO
The SPAC is sponsored by Goggo Network GmbH with the goal of combining with one or more businesses within the mobility industry.